

The $6 Million Drug ClaimAugust 26, 2019 |
New treatments for rare diseases are changing the lives of patients, but the price can reach millions of dollars for a single person
Quick Read
The $6 Million Drug ClaimAugust 26, 2019 |
New treatments for rare diseases are changing the lives of patients, but the price can reach millions of dollars for a single person
Quick Read
‘Maisie’s Army’August 20, 2019 |
How a grassroots group is mobilizing to help toddlers access a lifesaving drug
Quick ReadForced off their parents’ insurance and faced with high insulin prices, young adults dangerously ration, stockpile, and turn to the black market for the medication they need to stay alive
Quick Read
For Some Critical Drugs, Low Prices Lead to ScarcityJune 19, 2019 |
Shortages of “supportive care” drugs, for chemotherapy-induced nausea or to protect the kidneys, can delay cancer treatments, said Yoram Unguru, a pediatric oncologist & bioethicist at Sinai and the Johns Hopkins Berman Institute of Bioethics. When he gets the hospital’s list of shortages, “I scream, I shout, I shake my head”
Quick ReadMore than 40 states say the biggest drug makers engaged in “industry-wide conspiracy” to fix prices of generic drugs
Quick ReadNovartis AG is expected to begin selling Zolgensma, a possible cure for spinal muscular atrophy, after the FDA approves it this month. Novartis executives say Zolgensma’s ability to curb SMA—a muscle-wasting disease that often kills babies before age 2—explains the eye-popping price
Quick ReadSetting US drug prices based on prices paid in other countries could also improve affordability for Medicare beneficiaries according to a new study by researchers at Johns Hopkins, including our Michael DiStefano
Quick Read